{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-014068","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2022-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.136748+00:00","generated_at":"2026-06-23T19:14:23.808168+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"CytoDyn appoints Ryan Dunlap as director, effective Aug 25, 2022","bullets":["Ryan Dunlap appointed as director, filling vacancy from Nader Pourhassan's Jan 2022 resignation.","Expected to join the Audit Committee; Dunlap has over 25 years of finance and operations leadership.","Currently CFO at Gurobi Optimization; prior CFO at a publicly traded biotech/pharma sales company.","Compensation consistent with non-employee director policies; includes cash retainers and stock options.","No family relationships or transactions requiring disclosure under Item 404(a) of Regulation S-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-014068","json":"https://secwatch.observer/filing/0001558370-22-014068.json","markdown":"https://secwatch.observer/filing/0001558370-22-014068.md","text":"https://secwatch.observer/filing/0001558370-22-014068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022014068/0001558370-22-014068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022014068/cydy-20220824x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T19:14:23.808168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f624d9e3ef","claim":"Ryan Dunlap was appointed as director at CytoDyn Inc..","evidence_excerpt":"On August 24, 2022, the Board of Directors (the “Board”) of CytoDyn Inc. (the “Company”) approved the appointment of Ryan Dunlap (“Mr. Dunlap”), as a director of the Company, effective August 25, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022014068/0001558370-22-014068-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}